|
|
Article: NEJM Study Finds New Drug Improves Survival and Reduces Hospitalization in Patients Who Have Suffered a Heart Attack Complicated by Heart Failure.
- Article from:
- PR Newswire
- Article date:
- March 31, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK -- NEW YORK, March 31 /PRNewswire/ -- BACKGROUND: It is estimated that of the nearly five million heart failure patients in the U.S., 2.8 million had a heart attack which contributed to heart failure symptoms. More than 20 percent of male and nearly half of female heart attack victims will be disabled with heart failure within six years.
A study published in the April 3rd issue of the New England Journal of Medicine reports that a drug named INSPRA(TM) (eplerenone tablets), when given as a pill along with standard therapy for heart attack and heart failure, significantly reduced death and hospitalization among people who have recently suffered a heart ...